Medplus Health Services Ltd

Medplus Health Summary Chart Analysis Peers Quarters Profit & Loss Balance Sheet Cash Flow Ratios Investors Documents

Medplus Health Services Ltd

₹ 802 -2.41%
04 Nov 11:15 a.m.
medplusindia.com BSE: 543427 NSE: MEDPLUS
About
Key Points

India's Leading Pharmacy Company[1][2]
MedPlus is the 2nd largest pharmacy retailer in India, with 4,552 stores across 12 states and 1 union territory as of Q2 FY25. These stores are strategically distributed to maintain a high presence in metro, tier-one, and tier-two cities.

  • Store Distribution by Region[1]
  • Telangana: 679 stores
  • Andhra Pradesh: 454 stores
  • Karnataka: 893 stores
  • Tamil Nadu: 845 stores
  • West Bengal: 506 stores
  • Maharashtra: 553 stores
  • Odisha: 149 stores
  • Chhattisgarh: 4 stores
  • Madhya Pradesh: 4 stores
  • Puducherry: 5 stores
  • Delhi: 1 store

The stores increased with 108 net new stores added in Q2 FY2025, of which 71 were in Tier-2 and Tier-3 cities[3]

Website BSE NSE
  • Market Cap ₹ 9,612 Cr.
  • Current Price ₹ 802
  • High / Low ₹ 1,052 / 603
  • Stock P/E 49.2
  • Book Value ₹ 154
  • Dividend Yield 0.00 %
  • ROCE 10.3 %
  • ROE 8.80 %
  • Face Value ₹ 2.00
Edit ratios

Pros

Cons

  • Stock is trading at 5.24 times its book value
  • Though the company is reporting repeated profits, it is not paying out dividend
  • Company has a low return on equity of 5.51% over last 3 years.
  • Promoters have pledged or encumbered 59.3% of their holding.

* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.

Peer comparison

Consumer Discretionary Consumer Services Retailing Pharmacy Retail

Part of BSE 500 BSE SmallCap BSE Allcap BSE Consumer Discretionary BSE 250 SmallCap Index

Edit Columns
Loading peers table ...

Quarterly Results

Consolidated Figures in Rs. Crores / View Standalone

Sep 2022 Dec 2022 Mar 2023 Jun 2023 Sep 2023 Dec 2023 Mar 2024 Jun 2024 Sep 2024 Dec 2024 Mar 2025 Jun 2025 Sep 2025
1,121 1,190 1,253 1,284 1,409 1,441 1,490 1,489 1,576 1,561 1,510 1,543 1,679
1,061 1,119 1,171 1,213 1,324 1,350 1,385 1,395 1,452 1,429 1,373 1,412 1,530
Operating Profit 60 72 82 71 85 92 106 94 124 133 136 131 149
OPM % 5% 6% 7% 6% 6% 6% 7% 6% 8% 8% 9% 8% 9%
11 11 14 9 10 10 10 9 12 13 16 15 17
Interest 20 21 22 23 24 24 25 25 25 26 27 27 29
Depreciation 42 46 56 52 55 57 59 60 63 62 64 66 69
Profit before tax 9 16 17 5 16 20 32 18 48 57 61 53 69
Tax % 27% 17% -54% 26% 12% 31% -5% 19% 19% 19% 16% 20% 19%
6 13 27 4 15 14 34 14 39 46 51 42 56
EPS in Rs 0.55 1.12 2.23 0.32 1.22 1.15 2.79 1.20 3.24 3.83 4.29 3.54 4.63
Raw PDF

Profit & Loss

Consolidated Figures in Rs. Crores / View Standalone

Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025 TTM
1,368 1,733 2,011 2,131 2,273 2,871 3,069 3,779 4,558 5,625 6,136 6,293
1,336 1,696 1,940 2,073 2,153 2,737 2,852 3,507 4,292 5,270 5,648 5,745
Operating Profit 32 37 71 58 120 134 217 273 266 355 488 548
OPM % 2% 2% 4% 3% 5% 5% 7% 7% 6% 6% 8% 9%
4 8 7 8 11 17 21 31 46 40 48 61
Interest 14 17 19 28 50 47 55 66 83 96 103 109
Depreciation 9 10 11 12 59 75 88 119 182 224 250 261
Profit before tax 14 19 48 26 23 29 95 118 47 73 183 239
Tax % 46% 52% 40% -65% 48% 94% 34% 20% -6% 11% 18%
7 9 29 42 12 2 63 95 50 66 150 195
EPS in Rs 419.34 508.71 1,620.57 2,080.06 585.46 107.02 1,393.11 8.03 4.17 5.48 12.56 16.29
Dividend Payout % 0% 0% 0% 0% 0% 0% 0% 0% 0% 0% 0%
Compounded Sales Growth
10 Years: 16%
5 Years: 16%
3 Years: 18%
TTM: 5%
Compounded Profit Growth
10 Years: 34%
5 Years: 131%
3 Years: 16%
TTM: 95%
Stock Price CAGR
10 Years: %
5 Years: %
3 Years: 12%
1 Year: 22%
Return on Equity
10 Years: 7%
5 Years: 6%
3 Years: 6%
Last Year: 9%

Balance Sheet

Consolidated Figures in Rs. Crores / View Standalone

Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025 Sep 2025
Equity Capital 0.17 0.17 0.17 0.19 0.19 0.19 0.45 24 24 24 24 24
Reserves 141 137 148 303 291 528 730 1,394 1,467 1,554 1,717 1,821
170 223 204 162 429 477 590 815 900 1,010 1,120 1,193
126 149 183 179 239 344 245 361 406 417 500 534
Total Liabilities 438 509 535 644 959 1,349 1,566 2,594 2,797 3,005 3,360 3,572
67 77 81 83 377 419 517 799 1,138 1,242 1,296 1,355
CWIP 3 3 2 1 1 5 6 20 25 11 16 17
Investments 0 0 0 0 0 0 0 0 0 0 0 0
368 429 453 560 580 924 1,043 1,775 1,633 1,752 2,047 2,200
Total Assets 438 509 535 644 959 1,349 1,566 2,594 2,797 3,005 3,360 3,572

Cash Flows

Consolidated Figures in Rs. Crores / View Standalone

Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
-19 -17 34 32 147 -7 3 170 90 144 540
-16 -32 -15 -18 -19 -28 -35 -703 429 -83 -318
67 35 -29 -1 -83 90 -6 440 -170 -198 -228
Net Cash Flow 32 -15 -10 14 45 56 -37 -93 350 -137 -5

Ratios

Consolidated Figures in Rs. Crores / View Standalone

Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
Debtor Days 1 1 0 2 1 1 1 1 1 1 1
Inventory Days 84 82 76 76 78 101 113 112 117 111 106
Days Payable 34 29 25 27 31 37 22 30 27 21 24
Cash Conversion Cycle 51 53 51 51 48 65 91 82 91 92 83
Working Capital Days 16 12 14 13 8 25 46 100 58 58 54
ROCE % 11% 19% 13% 12% 9% 13% 10% 5% 7% 10%

Shareholding Pattern

Numbers in percentages

2 Recently
Dec 2022Mar 2023Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025
40.43% 40.43% 40.43% 40.41% 40.45% 40.39% 40.39% 40.39% 40.39% 40.33% 40.32% 40.29%
3.94% 4.48% 4.87% 12.36% 12.96% 14.94% 14.85% 14.72% 15.23% 15.61% 16.43% 16.53%
28.77% 28.16% 28.13% 25.50% 25.19% 22.47% 22.17% 27.98% 25.66% 26.19% 26.03% 26.51%
26.56% 26.73% 26.42% 21.61% 21.31% 22.10% 22.51% 16.85% 18.68% 17.82% 17.18% 16.60%
0.29% 0.19% 0.15% 0.12% 0.10% 0.10% 0.08% 0.07% 0.05% 0.05% 0.05% 0.05%
No. of Shareholders 74,70273,51270,01766,43066,04874,97676,93487,32883,91283,43981,74278,337

* The classifications might have changed from Sep'2022 onwards. The new XBRL format added more details from Sep'22 onwards.

Classifications such as banks and foreign portfolio investors were not available earlier. The sudden changes in FII or DII can be because of these changes.

Click on the line-items to see the names of individual entities.

Documents

Announcements

Annual reports

DRHP

Concalls